IldikoKovacsMD

Clinical Trials

• Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) Versus Placebo Start of enrollment: 2013 Jul 01Ahern, G.,Bernick, C.B.,Biunno, M.J.,Borresen, T.E.,Boxer, A.L.,Brody, M.L.,Burch, J.G.,Burns, J.M.,Capote, H.,Chakraburtty, A.,Cohen, R.A.,Curtis, C.T.,Dempsey, G.M.,Dequardo, J.R.,Dibuono, M.,Dinnerstei...
• A 26-Week, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Effects of Daily Administration of AC-1204 in Participants With Mild to Moderate Alzheimer's Disease (AD) With an Optional 26-Week Open Label Extension Start of enrollment: 2013 Mar 01Jeffrey Gitt, DO, Allison Perrin, MD, Gordon Gibson, MD, Victor Biton, MD, John Murphy, MD, Gustavo Alva, MD, Elizabeth Zarate-Rowell, MD, Michael Rafii, MD, PhD, Robert Feldman, MD, Omid Omidvar, MD, Ild...